Novel pharmaceutically acceptable salts of 4-(1H-imidazol-4-ylmethyl)pyridine and their therapeutical uses

Details for Australian Patent Application No. 2010251154 (hide)

Owner Bioprojet

Inventors Capet, Marc; Labeeuw, Olivier; BerrebiBertrand, Isabelle; Robert, Philippe; Ligneau, Xavier; Lecomte, JeanneMarie; Schwartz, Jean-Charles

Agent Davies Collison Cave

Pub. Number AU-A-2010251154

PCT Pub. Number WO2010/133598

Priority 09305456.7 19.05.09 EP

Filing date 18 May 2010

Wipo publication date 25 November 2010

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/133598 Priority application(s): WO2010/133598

24 May 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Apr 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010251156-Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB

2010251151-Parmaceutical composition for the treatment of heart diseases.